T

Tango Therapeutics

Develops synthetic-lethality cancer therapies

Associate Director - Statistical Programming

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeBoston, MA, USA$172k - $258kIn-person

About the Job

Requirements

  • A bachelor's or master's degree in statistics, life sciences, computer science, or a related field and at least 8 years of statistical programming experience.
  • A solid understanding of industry standards applicable to clinical study data and regulatory reporting requirements, including electronic Common Technical Document (eCTD) and Clinical Data Interchange Standards Consortium (CDISC) implementation.
  • Expert-level expertise in Statistical Analysis System (SAS) programming, including Base, Macro, STAT, GRAPH, and SQL, with experience delivering complex programming assignments, macros, and analyses.
  • Experience with R and Python.
  • Extensive experience in early-phase clinical studies, including programming and validation of Study Data Tabulation Model (SDTM) and Analysis Data Model (ADaM) datasets, tables, listings, and figures.
  • Experience managing contract research organizations (CROs) for outsourced statistical programming activities.
  • Expertise in the requirements and technology supporting electronic submissions.
  • Experience with Biologics License Application (BLA) or New Drug Application (NDA)/supplemental NDA (sNDA) submissions to the U.S. Food and Drug Administration (FDA) or European Medicines Agency (EMA).

Responsibilities

  • Lead and manage statistical programming activities for clinical trials and studies, delivering high-quality and timely clinical study reports (CSRs), publications, presentations, health authority submission reports, clinical data reviews, and ad hoc analyses internally or through CRO partners.
  • Develop, validate, and maintain SDTM and ADaM analysis datasets, tables, listings, and figures (TLFs) in accordance with regulatory guidelines and internal standards.
  • Review key clinical study or program documents.
  • Perform complex statistical analyses and simulations using SAS to support clinical trial design and data interpretation; manage macro libraries and templates for preparing, processing, and analyzing clinical data and validating analysis results.
  • Provide statistical programming expertise for regulatory submissions, including FDA and EMA submissions and eCTD standards.
  • Participate in the Data Governance Team to build and maintain secure statistical computing and programming infrastructure.
  • Collaborate with biostatisticians, data managers, and cross-functional team members to define programming strategies and requirements, establish project timelines, and perform statistical analyses.
  • Manage and oversee CROs to ensure high-quality statistical analysis deliverables, including datasets and TLFs, within timelines and budget.
  • Author or review SDTM and ADaM specifications to ensure compliance with CDISC standards.
  • Develop SAS code and manage macro libraries and templates for preparing, processing, and analyzing clinical data and validating analysis results.
  • Author or review statistical analysis-related standard operating procedures (SOPs).
  • Stay current with industry trends, best practices, and emerging technologies in statistical programming and data analysis.
  • Perform additional duties and responsibilities as required.

Desired Qualifications

  • Experience in oncology.

About the Company

Tango Therapeutics

Develops synthetic-lethality cancer therapies

Tango Therapeutics develops cancer medicines by leveraging synthetic lethality to selectively kill cancer cells while sparing healthy cells. Its approach focuses on creating drugs that exploit interactions between gene pairs, aiming for targeted therapies that spare normal tissue. The company advances its treatments through a strong R&D program and collaborates with larger pharmaceutical partners, such as Gilead Sciences, to co-develop therapies and accelerate commercialization. Revenue comes from these partnerships and funding rounds like its Series B. Tango differentiates itself with a dedicated emphasis on genetically targeted cancer therapies, a robust pipeline, and leadership that guides strategic collaborations. The company’s goal is to bring next-generation, genetically targeted immunotherapies to market, improving outcomes for cancer patients by precisely targeting tumor biology.

Company size
51-200
Company stage
IPO
Headquarters
Boston, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Tango Therapeutics

See more jobs